Home LiteratureArticle Details
PMID: 10839807 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

The Journal of experimental medicine ·Vol. 191 ·No. 11 ·2000-06-05 ·Pages 1921-31

Metzner KJ, Jin X, Lee FV, Gettie A, Bauer DE, Di Mascio M, Perelson AS, Marx PA, Ho DD, Kostrikis LG, Connor RI

Abstract

The role of CD8(+) T lymphocytes in controlling replication of live, attenuated simian immunodeficiency virus (SIV) was investigated as part of a vaccine study to examine the correlates of protection in the SIV/rhesus macaque model. Rhesus macaques immunized for >2 yr with nef-deleted SIV (SIVmac239Deltanef) and protected from challenge with pathogenic SIVmac251 were treated with anti-CD8 antibody (OKT8F) to deplete CD8(+) T cells in vivo. The effects of CD8 depletion on viral load were measured using a novel quantitative assay based on real-time polymerase chain reaction using molecular beacons. This assay allows simultaneous detection of both the vaccine strain and the challenge virus in the same sample, enabling direct quantification of changes in each viral population. Our results show that CD8(+) T cells were depleted within 1 h after administration of OKT8F, and were reduced by as much as 99% in the peripheral blood. CD8(+) T cell depletion was associated with a 1-2 log increase in SIVmac239Deltanef plasma viremia. Control of SIVmac239Deltanef replication was temporally associated with the recovery of CD8(+) T cells between days 8 and 10. The challenge virus, SIVmac251, was not detectable in either the plasma or lymph nodes after depletion of CD8(+) T cells. Overall, our results indicate that CD8(+) T cells play an important role in controlling replication of live, attenuated SIV in vivo.

MeSH Terms
Animals Antigens, CD20/immunology CD8-Positive T-Lymphocytes/immunology DNA, Viral/blood Lymph Nodes/pathology,virology Lymphocyte Depletion Macaca mulatta RNA, Viral/blood Receptors, IgG/immunology Simian Immunodeficiency Virus/genetics,immunology,physiology Vaccination Vaccines, Attenuated Viral Load Viral Vaccines/immunology Virus Replication/immunology
Chemicals
Antigens, CD20 DNA, Viral RNA, Viral Receptors, IgG Vaccines, Attenuated Viral Vaccines
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Metzner K J
Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10016, USA.
Jin X
Lee F V
Gettie A
Bauer D E
Di Mascio M
Perelson A S
Marx P A
Ho D D
Kostrikis L G
Connor R I
References (45)
45 references, click to expand
  1. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.
    J Gen Virol. 1997 Aug;78 ( Pt 8):1923-7 PMID: 9266989
  2. Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.
    J Clin Immunol. 1992 May;12(3):170-7 PMID: 1400897
  3. Protective immunity induced by live attenuated simian immunodeficiency virus.
    Curr Opin Immunol. 1998 Aug;10(4):436-43 PMID: 9722920
  4. Multicolor molecular beacons for allele discrimination.
    Nat Biotechnol. 1998 Jan;16(1):49-53 PMID: 9447593
  5. Spectral genotyping of human alleles.
    Science. 1998 Feb 20;279(5354):1228-9 PMID: 9508692
  6. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
    N Engl J Med. 1995 Jan 26;332(4):201-8 PMID: 7808485
  7. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques.
    Nat Med. 1995 Nov;1(11):1167-73 PMID: 7584989
  8. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Virology. 1995 Oct 1;212(2):392-7 PMID: 7571408
  9. Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge.
    J Gen Virol. 1999 Jul;80 ( Pt 7):1569-1574 PMID: 10423123
  10. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
    Nat Med. 1999 Nov;5(11):1270-6 PMID: 10545993
  11. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
    Virology. 1996 May 1;219(1):195-205 PMID: 8623530
  12. Molecular beacons: probes that fluoresce upon hybridization.
    Nat Biotechnol. 1996 Mar;14(3):303-8 PMID: 9630890
  13. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.
    J Virol. 1998 Jan;72(1):164-9 PMID: 9420212
  14. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.
    J Virol. 1994 Apr;68(4):2362-70 PMID: 8139022
  15. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.
    J Virol. 1999 Jan;73(1):436-43 PMID: 9847349
  16. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
    Nat Med. 1999 Feb;5(2):194-203 PMID: 9930868
  17. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
    J Virol. 1996 Jun;70(6):3724-33 PMID: 8648707
  18. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.
    J Virol. 1997 Nov;71(11):8141-8 PMID: 9343164
  19. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
    AIDS. 1998 Dec 3;12(17):2261-70 PMID: 9863867
  20. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1221-31 PMID: 2078405
  21. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    J Gen Virol. 1996 Dec;77 ( Pt 12):2969-81 PMID: 9000087
  22. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  23. Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.
    AIDS Res Hum Retroviruses. 1998 Sep 1;14(13):1187-98 PMID: 9737590
  24. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Virology. 2000 Jan 5;266(1):203-10 PMID: 10612675
  25. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines.
    J Virol. 1998 Oct;72(10):7846-51 PMID: 9733821
  26. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  27. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
    J Exp Med. 1998 Apr 20;187(8):1295-303 PMID: 9547340
  28. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
    J Virol. 1999 Oct;73(10):8356-63 PMID: 10482586
  29. Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.
    J Virol. 1999 Feb;73(2):1262-70 PMID: 9882330
  30. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys.
    J Immunol. 1996 Dec 15;157(12):5528-35 PMID: 8955203
  31. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction.
    AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):183-9 PMID: 9462929
  32. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
    J Virol. 1997 Oct;71(10):7711-8 PMID: 9311855
  33. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.
    J Gen Virol. 1997 Aug;78 ( Pt 8):1919-22 PMID: 9266988
  34. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV.
    J Virol. 1998 Aug;72(8):6315-24 PMID: 9658070
  35. The influence of OKT8F treatment on allograft survival in rhesus monkeys.
    Transplantation. 1986 Apr;41(4):431-5 PMID: 3083541
  36. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.
    J Virol. 1993 Mar;67(3):1707-11 PMID: 8437240
  37. A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys.
    J Med Primatol. 1997 Feb-Apr;26(1-2):51-8 PMID: 9271189
  38. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine.
    AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1253-62 PMID: 9764909
  39. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  40. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    J Virol. 1998 Sep;72(9):7501-9 PMID: 9696847
  41. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
    J Virol. 1995 May;69(5):2737-44 PMID: 7707496
  42. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
    Science. 1995 Mar 24;267(5205):1820-5 PMID: 7892606
  43. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.
    Virology. 1997 Mar 3;229(1):143-54 PMID: 9123856
  44. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Science. 1992 Dec 18;258(5090):1938-41 PMID: 1470917
  45. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.
    J Virol. 1994 Nov;68(11):7021-9 PMID: 7933084
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2000-06-05
Pages
1921-31
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2213531
Subset
IM
Grants
NIAID NIH HHS · AI43868 · United States
NCRR NIH HHS · RR06555 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com